Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Clopidogrel bisulfate
Drug ID BADD_D00505
Description Clopidogrel is a prodrug of a platelet inhibitor used to reduce the risk of myocardial infarction and stroke.[A180508,L7213] Clopidogrel is indicated to reduce the risk of myocardial infarction for patients with non-ST elevated acute coronary syndrome (ACS), patients with ST-elevated myocardial infarction, and in recent MI, stroke, or established peripheral arterial disease,[L7213] It has been shown to be superior to [aspirin] in reducing cardiovascular outcomes in patients with cardiovascular disease and provides additional benefit to patients with acute coronary syndromes already taking aspirin.[A180547] Clopidogrel was granted FDA approval on 17 November 1997.[L7213]
Indications and Usage For the reduction of atherosclerotic events (myocardial infarction, stroke, and vascular death) in patients with atherosclerosis documented by recent stroke, recent myocardial infarction, or established peripheral arterial disease.
Marketing Status Prescription; Discontinued
ATC Code B01AC04
DrugBank ID DB00758
KEGG ID D00769
MeSH ID D000077144
PubChem ID 115366
TTD Drug ID D0N0TZ
NDC Product Code 43063-371; 66577-037; 60505-3992; 51407-032; 68788-7700; 50090-1300; 62147-0007; 63187-639; 50228-124; 65862-372; 53360-1171; 72640-009; 71335-1646; 68578-0014; 50090-2082; 50379-0015; 50268-184; 71335-1232; 50370-0040; 0904-6467; 50228-121; 55111-196; 77777-109; 68084-536; 55154-3376; 60505-0253; 0904-6294; 68166-005; 72969-015; 60429-301; 53002-1672; 12666-0019; 68645-590; 63310-2440; 13668-141; 71796-027; 50090-1301; 50090-5330; 47335-894; 71052-296; 55111-671; 73680-0002; 65862-357; 71335-0080; 55289-911; 63629-8045; 64980-343; 69367-194; 71335-0752; 70934-797; 53104-7582; 58118-0357; 0615-8014; 68071-4268; 71610-527; 71205-073; 60505-3532; 14501-0026; 42765-004; 68084-752; 64220-103
Synonyms Clopidogrel | SC 25989C | SC 25990C | SR 25989 | Clopidogrel-Mepha | Clopidogrel Mepha | Clopidogrel Sandoz | Iscover | Clopidogrel Napadisilate | Clopidogrel Hydrochloride | PCR 4099 | PCR-4099 | Clopidogrel Besylate | Clopidogrel Besilate | Clopidogrel, (+)(S)-isomer | Plavix | Clopidogrel Bisulfate
Chemical Information
Molecular Formula C16H18ClNO6S2
CAS Registry Number 120202-66-6
SMILES COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3.OS(=O)(=O)O
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Acute hepatic failure09.01.03.001--Not Available
Agranulocytosis01.02.03.001--Not Available
Anaphylactoid reaction24.06.03.007; 10.01.07.003--Not Available
Angioedema23.04.01.001; 10.01.05.009--Not Available
Aplastic anaemia01.03.03.002--Not Available
Arthralgia15.01.02.001--
Arthritis15.01.01.001--
Blindness17.17.01.003; 06.02.02.001--Not Available
Blood creatinine increased13.13.01.004--
Bronchospasm22.03.01.004; 10.01.03.012--
Cerebral haemorrhage24.07.04.001; 17.08.01.003--Not Available
Colitis07.08.01.001--
Colitis ulcerative10.02.01.004; 07.08.01.005--Not Available
Confusional state19.13.01.001; 17.02.03.005--
Conjunctival haemorrhage24.07.05.001; 06.07.01.001--Not Available
Death08.04.01.001--
Dermatitis bullous23.03.01.002--
Diarrhoea07.02.01.001--
Disability26.01.01.003--Not Available
Duodenal ulcer07.04.02.002--
Dysgeusia17.02.07.003; 07.14.03.001--
Eczema23.03.04.006--
Eosinophilic pneumonia22.01.01.004; 01.02.04.003--Not Available
Epistaxis24.07.01.005; 22.04.03.001--
Erythema multiforme23.03.01.003; 10.01.03.015--
Eye haemorrhage24.07.05.002; 06.07.02.001--Not Available
Gastric ulcer07.04.03.002--
Gastrointestinal haemorrhage24.07.02.009; 07.12.02.001--Not Available
Haematoma24.07.01.001--
Haematuria24.07.01.047; 20.02.01.006--
The 1th Page    1 2 3    Next   Last    Total 3 Pages